-+ 0.00%
-+ 0.00%
-+ 0.00%

Bluejay Diagnostics Outlines 2026 Plans to Complete SYMON II Study, Advance Toward Regulatory Submission, Scale Manufacturing for Commercialization and Raise Additional Capital

Reuters·03/06/2026 14:22:29

Please log in to view news